Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

'All Comer'/'Real-world' Registry-based Randomized, Prospective, Multicenter Clinical Trial to Evaluate the Incidence of Complications Using Novosyn® CHD Suture Versus Polyglactin 910 Suture to Close the Wound After Emergency or Elective Laparotomy or Laparoscopic Surgery

NCT05966961 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT05966961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05966961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
'All Comer'/'Real-world' Registry-based Randomized, Prospective, Multicenter Clinical Trial to Evaluate the Incidence of Complications Using Novosyn® CHD Suture Versus Polyglactin 910 Suture to Close the Wound After Emergency or Elective Laparotomy or Laparoscopic Surgery
Lead sponsor
Aesculap AG
Phase
Observational
Overall status
Recruiting
Start date
September 18, 2023
Completion date
December 31, 2028
Enrollment
2,998 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

surgical site infection